← Browse by Condition
Medical Condition
atherosclerotic cardiovascular disease
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 3
NCT07037433 Phase 3
Recruiting
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Enrollment
12,800 pts
Location
United States, Argen...
Sponsor
Amgen
NCT05765370
Recruiting
LDL Cholesterol TARGETs in OLDer Patients (Age≥75 Years) With ASCVD (TARGET OLD)
Enrollment
4,200 pts
Location
China
Sponsor
China National Center for Card...